Revenue: The sum of all revenue fields included for a company's operating activities.
Bioxytran, Inc. (BIXT) Revenue data is not available for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
-- |
$-2.37M |
|
-- |
|
-- |
|
$2.22M |
|
$-2.22M |
|
$-0.16M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.22M |
|
$-1.54M |
|
138.60M |
|
138.60M |
|
$-0.02 |
|
$-0.02 |
|
Balance Sheet Financials | |
$0.01M |
|
-- |
|
$0.13M |
|
$0.14M |
|
$1.93M |
|
-- |
|
-- |
|
$1.93M |
|
$-1.84M |
|
$-1.93M |
|
$-1.79M |
|
86.78M |
|
Cash Flow Statement Financials | |
$-0.06M |
|
$-0.03M |
|
$0.06M |
|
$0.03M |
|
$0.01M |
|
$-0.02M |
|
$0.63M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.00 |
|
-- |
|
-- |
|
-- |
|
-0.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
129.69% |
|
123.61% |
|
-1716.01% |
|
132.82% |
|
$-0.02 |
|
$-0.00 |
|
$-0.00 |